Evidence map›Paper›PMID 35493894›Full record

ArticleRSC advances2020

Didymellanosine, a new decahydrofluorene analogue, and ascolactone C from

Ni P Ariantari, Elena Ancheeva, Marian Frank, Fabian Stuhldreier, Dieter Meier, Yvonne Gröner, Irene Reimche, Nicole Teusch, Sebastian Wesselborg, Werner E G Müller and 3 more

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Synthesis of an A/B-Organic letters · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 6 countries.

Ni P AriantariInstitute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany zhenfeizi0@sina.com proksch@uni-duesseldorf.de.
Elena AncheevaInstitute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany zhenfeizi0@sina.com proksch@uni-duesseldorf.de.ORCID https://orcid.org/0000-0002-2440-4427
Marian FrankInstitute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany zhenfeizi0@sina.com proksch@uni-duesseldorf.de.
Fabian StuhldreierInstitute of Molecular Medicine I, Medical Faculty, Heinrich Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany.
Dieter MeierInstitute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany zhenfeizi0@sina.com proksch@uni-duesseldorf.de.
Yvonne GrönerInstitute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany zhenfeizi0@sina.com proksch@uni-duesseldorf.de.
Irene ReimcheDepartment of Biomedical Sciences, Institute of Health Research and Education, University of Osnabrück Germany.
Nicole TeuschDepartment of Biomedical Sciences, Institute of Health Research and Education, University of Osnabrück Germany.
Sebastian WesselborgInstitute of Molecular Medicine I, Medical Faculty, Heinrich Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany.
Werner E G MüllerInstitute for Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz Duesbergweg 6 55128 Mainz Germany.ORCID https://orcid.org/0000-0002-8223-3689
Rainer KalscheuerInstitute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany zhenfeizi0@sina.com proksch@uni-duesseldorf.de.
Zhen LiuInstitute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany zhenfeizi0@sina.com proksch@uni-duesseldorf.de.ORCID https://orcid.org/0000-0003-3314-7853
Peter ProkschInstitute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University Düsseldorf Universitätsstrasse 1 40225 Düsseldorf Germany zhenfeizi0@sina.com proksch@uni-duesseldorf.de.
Pharmaceutical Biotechnology (Czechia) · CZFaculty (United Kingdom) · GBOsnabrück University · DEChina Three Gorges University · CNUdayana University · IDUniversity of Applied Sciences Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Didymellanosine (1), the first analogue of the decahydrofluorene-class of natural products bearing a 13-membered macrocyclic alkaloid conjugated with adenosine, and a new benzolactone derivative, ascolactone C (4) along with eight known compounds (2, 3, 5-10), were isolated from a solid rice fermentation of the endophytic fungus

Identifiers

PMID35493894
PMCPMC9049863
OpenAlexW3006967385

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.